Chemoreactome screening of pharmaceutical effects on SARS-CoV-2 and human virome to help decide on drug-based COVID-19 therapy
Background. So-called rational drug design is suboptimal when it comes to finding effective and safe drug-based treatment for COVID-19. Another approach seems promising: to reprofile the pharmaceuticals registered in the Anatomical, Therapeutic, and Chemical Classifier (ATC).Material and methods. Ch...
Saved in:
Main Authors: | I. Yu. Torshin, O. A. Gromova, A. G. Chuchalin, Yu. I. Zhuravlev |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2021-07-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/527 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Prospects of using chondroprotectors for the treatment of pulmonary pathology
by: I. Yu. Torshin, et al.
Published: (2022-01-01) -
Hepatoprotective effects of chondroitin sulfate and glucosamine sulfate
by: I. Yu. Torshin, et al.
Published: (2022-01-01) -
Chemoreactome analysis of the antithrombotic effects of glucosamine sulfate and nonsteroidal anti-inflammatory drugs
by: O. A. Gromova, et al.
Published: (2019-03-01) -
Pharmacoinformation studies of chondroprotectors
by: A. M. Lila, et al.
Published: (2021-10-01) -
Differential chemoreactome analysis of glucosamine sulfate and non-steroidal anti-inflammatory drugs: promising synergistic drug combinations
by: O. A. Gromova, et al.
Published: (2018-06-01)